The DOI matches its Crossref record; 269 of the 269 references it cites were found in a registry or an index.
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–269 of 269
Moroni, M., Vijayan, R., Carbone, A. L., Zwart, R., Biggin, P. C., & Bermúdez, I. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1228-08.2008 · Cited by 81
Whitehouse, P. J., & Kalaria, R. N. (1995) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199501002-00002 · Cited by 79
Lamb, P. W., Melton, M. A., & Yakel, J. L. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:1:013 · Cited by 79
Shytle, R. D., Silver, A. A., Sheehan, K. H., Sheehan, D. V., & Sanberg, P. R. (2002) · Depression and Anxiety · doi:10.1002/da.10035 · Cited by 77
Hamouda, A. K., Chiara, D. C., Sauls, D., et al. (2005) · Biochemistry · doi:10.1021/bi051978h · Cited by 77
Hahn, B., Shoaib, M., & Stolerman, I. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1438-6 · Cited by 75
Rosse, R. B., & Deutsch, S. I. (2002) · Clinical Neuropharmacology · doi:10.1097/00002826-200209000-00010 · Cited by 74
Hennings, E. C. P., Kiss, J., Oliveira, K. D., Tóth, P. T., & Vizi, E. S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731043.x · Cited by 74
Popik, P., Kozela, E., & Krawczyk, M. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705359 · Cited by 74
Kinetic, Mechanistic, and Structural Aspects of Unliganded Gating of Acetylcholine Receptor Channels
Grosman, C. F., & Auerbach, A. L. (2000) · The Journal of General Physiology · doi:10.1085/jgp.115.5.621 · Cited by 73
Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors
Hogg, R. C., & Bertrand, D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.010 · Cited by 72
Small, D. H., Maksel, D., Kerr, M. L., Ng, J., Hou, X., Chu, C., Mehrani, H., Unabia, S., Azari, M. F., Loiacono, R., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04444.x · Cited by 69
Colquhoun, D., & Sakmann, B. J. (1998) · Neuron · doi:10.1016/s0896-6273(00)80982-4 · Cited by 69
Nirthanan, S., García, G., Chiara, D. C., Husain, S. S., & Cohen, J. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801332200 · Cited by 66
Nicotinic Acetylcholine receptors: from molecular biology to cognition
Davenport, A. P. (2006) · British Journal of Neurosurgery · doi:10.1080/02688690600682770 · Cited by 66
Kabbani, N., Woll, M. P., Levenson, R. G., Lindstrom, J. M., & Changeux, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710314104 · Cited by 66
Self-citationNicotinic receptors and Alzheimer's disease
Bourin, M., Ripoll, N., & Dailly, É. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125001631 · Cited by 65
Toxin insights into nicotinic acetylcholine receptors
Dutertre, S., & Lewis, R. J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.027 · Cited by 64
Blanton, M., Xie, Y., Dangott, L. J., & Cohen, J. B. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.2.269 · Cited by 63
β2 Subunit Contribution to 4/7 α-Conotoxin Binding to the Nicotinic Acetylcholine Receptor
Dutertre, S., Nicke, A., & Lewis, R. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504229200 · Cited by 63
Zheng, G., Dwoskin, L. P., Deaciuc, A. G., Norrholm, S. D., & Crooks, P. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0501228 · Cited by 63
Curzon, P., Anderson, D. J., Nikkel, A. L., Fox, G. B., Gopalakrishnan, M., Decker, M. W., & Bitner, R. S. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.09.061 · Cited by 62
Phosphorylation of the Nicotinic Acetylcholine Receptor by Protein Tyrosine Kinasesa
Swope, S. L., Qu, Z., & Huganir, R. L. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17476.x · Cited by 59
Jóźwiak, K., Ravichandran, S., Collins, J., & Wainer, I. W. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0400707 · Cited by 59
Keller, J. J., Keller, A. B., Bowers, B. J., & Wehner, J. M. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.03.004 · Cited by 57
Nicotinic acetylcholine receptor antagonist effect of fluoxetine in rat hippocampal slices
Hennings, E. C. P., Kiss, J. P., & Vizi, E. S. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00343-0 · Cited by 55
Lieberman, J. A., Javitch, J. A., & Moore, H. M. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08050769 · Cited by 54
A structural model of agonist binding to the α3β4 neuronal nicotinic receptor
Costa, V., Nistri, A., Cavalli, A., & Carloni, P. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705498 · Cited by 54
Attention-deficit/hyperactivity disorder: A plausible mouse model?
Granon, S., & Changeux, J. (2006) · Acta Paediatrica · doi:10.1080/08035250600719747 · Cited by 53
Self-citationNovel α7 nicotinic receptor isoforms and deficient cholinergic transcription in schizophrenia
Severance, E. G., & Yolken, R. H. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00323.x · Cited by 52
Effects of fluoxetine on wild and mutant neuronal α7 nicotinic receptors
Maggi, L., Palma, E., Miledi, R., & Eusebi, F. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000392 · Cited by 52
In SilicoModels for the Human α4β2 Nicotinic Acetylcholine Receptor
Haddadian, E. J., Cheng, M. H., Coalson, R. D., Xu, Y., & Tang, P. S. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp804868s · Cited by 49
Determinants of Zinc Potentiation on the α4 Subunit of Neuronal Nicotinic Receptors
Hsiao, B., Mihalak, K. B., Repicky, S. E., Everhart, D., Mederos, A. H., Malhotra, A., & Luetje, C. W. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015164 · Cited by 47
Yi, M., Tjong, H., & Zhou, H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710530105 · Cited by 47
Huang, X., Zheng, F., Crooks, P. A., Dwoskin, L. P., & Zhan, C. (2005) · Journal of the American Chemical Society · doi:10.1021/ja052681+ · Cited by 45
Huang, X., Zheng, F., Chen, X., Crooks, P. A., Dwoskin, L. P., & Zhan, C. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0606701 · Cited by 43
Nicotinic receptors as targets for therapeutic discovery
Lippiello, P., Bencherif, M., Hauser, T. A., Jordan, K., Letchworth, S., & Mazurov, A. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.9.1185 · Cited by 43
Determination of α‐conotoxin binding modes on neuronal nicotinic acetylcholine receptors
Dutertre, S., Nicke, A., Tyndall, J. D. A., & Lewis, R. J. (2004) · Journal of Molecular Recognition · doi:10.1002/jmr.683 · Cited by 43
Shytle, R. D., Silver, A. A., & Sanberg, P. R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00945-8 · Cited by 41
Ji, J., Bunnelle, W. H., Anderson, D. J., Faltynek, C. R., Dyhring, T., Ahring, P. K., Rueter, L. E., Curzon, P., Buckley, M. J., Marsh, K. C., et al. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.010 · Cited by 41
Martin, S. E., de Fiebre, N. E. C., & de Fiebre, C. M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.016 · Cited by 39
Blanton, M., McCardy, E. A., Huggins, A., & Parikh, D. S. (1998) · Biochemistry · doi:10.1021/bi981435q · Cited by 39
Lyukmanova, E. N., Shenkarev, Z. O., Schulga, A. A., Ermolyuk, Y. S., Mordvintsev, D. Y., Utkin, Y. N., Shoulepko, M. A., Hogg, R. C., Bertrand, D., Dolgikh, D. A., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611263200 · Cited by 35
Transgenic mice over-expressing human β-amyloid have functional nicotinic alpha 7 receptors
Spencer, J. P., Weil, A., Hill, K., Hussain, I., Richardson, J. C., Cusdin, F. S., Chen, Y. H., & Randall, A. D. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.007 · Cited by 35
López‐Hernández, G. Y., Placzek, A. N., Thinschmidt, J. S., Lestage, P. J., Trocmé, C., Morain, P., & Papke, R. L. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.04.007 · Cited by 35
Self-citationSamson, A. O., & Levitt, M. (2008) · Biochemistry · doi:10.1021/bi702272j · Cited by 34
Horenstein, N. A., McCormack, T. J., Stokes, C. A., Ren, K., & Papke, R. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609202200 · Cited by 30
Huang, X., Zheng, F., Stokes, C. A., Papke, R. L., & Zhan, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800607u · Cited by 29
Lee, Y., Rudell, J. B., Yechikhov, S., Taylor, R., Swope, S. L., & Ferns, M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.03.009 · Cited by 28
Genetic linkage to schizophrenia at chromosome 15q14
Freedman, R., & Leonard, S. S. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1548 · Cited by 27
Curzon, P., Brioni, J. D., & Decker, M. W. (1996) · Brain Research · doi:10.1016/0006-8993(95)01536-1 · Cited by 27
Nievas, G. A. F., Barrantes, F. J., & Antollini, S. S. (2007) · Biochemistry · doi:10.1021/bi061388z · Cited by 26
Mourot, A., Grütter, T., Goeldner, M. P., & Kotzyba‐Hibert, F. (2006) · ChemBioChem · doi:10.1002/cbic.200500526 · Cited by 26
Corringer, P., Bertrand, S., Galzi, J., Devillers‐Thiéry, A., Changeux, J., & Bertrand, D. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515716.ch14 · Cited by 24
Self-citationCongenital myasthenic syndromes: A diverse array of molecular targets
Engel, A. G., Ohno, K., & Sine, S. M. (2003) · Journal of Neurocytology · doi:10.1023/b:neur.0000020639.22895.28 · Cited by 24
Li, X. D., & Buccafusco, J. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053785 · Cited by 23
Gay, E. A., Bienstock, R. J., Lamb, P. W., & Yakel, J. L. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035527 · Cited by 21
Computer modeling of binding of diverse weak toxins to nicotinic acetylcholine receptors
Mordvitsev, D. Y., Polyak, Y. L., Kuzmin, D., Levtsova, O. V., Tourleigh, Y. V., Utkin, Y. N., Шайтан, К. В., & Tsetlin, V. I. (2007) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2007.02.011 · Cited by 21
Yuan, H., & Petukhov, P. A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.07.049 · Cited by 21
Bisson, W. H., Scapozza, L., Westera, G., Mu, L., & Schubiger, P. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040881a · Cited by 21
Dunbar, G., Demazières, A., Monreal, A., Cisterni, C., Metzger, D., Kuchibhatla, R., & Luthringer, R. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006288730 · Cited by 20
Hansen, S. B., Sulzenbacher, G., Huxford, T., Marchot, P., Bourne, Y., & Taylor, P. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:30:1:101 · Cited by 19
Neuroprotection in alzheimer’s disease — new strategies for treatment
Nordberg, A. K. (2000) · Neurotoxicity Research · doi:10.1007/bf03033791 · Cited by 17
Nicotinic Regulation of Calcium/Calmodulin-Dependent Protein Kinase II Activation in the Spinal Cord
Damaj, M. I. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111336 · Cited by 16
Docking of α-cobratoxin suggests a basal conformation of the nicotinic receptor
Konstantakaki, M., Changeux, J., & Taly, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.126 · Cited by 15
Self-citationOpened by a twist: a gating mechanism for the nicotinic acetylcholine receptor
Taly, A. (2007) · European Biophysics Journal · doi:10.1007/s00249-007-0189-4 · Cited by 14
Self-citationSzász, B. K., Vizi, E. S., & Kiss, J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.032 · Cited by 11
Wonnacott, S. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707583 · Cited by 10
Konstantakaki, M., Tzartos, S. J., Poulas, K. A., & Eliopoulos, E. (2008) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2008.01.004 · Cited by 9
Cited by
Talele, T. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00472 · Cited by 1,023
Modes and models of forebrain cholinergic neuromodulation of cognition
Hasselmo, M. E., & Sarter, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.104 · Cited by 733
Resolving postoperative neuroinflammation and cognitive decline
Terrando, N., Eriksson, L. I., Kyu Ryu, J., Yang, T., Monaco, C., Feldmann, M., Jonsson Fagerlund, M., Charo, I. F., Akassoglou, K., & Maze, M. (2011) · Annals of Neurology · doi:10.1002/ana.22664 · Cited by 579
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R., Rollema, H., & Bertrand, D. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 522
Logue, S. F., & Gould, T. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.08.007 · Cited by 477
Metadata
- Authors
- Taly, A., Corringer, P.-J., Guedin, D., Lestage, P., & Changeux, J.-P.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-09
- Volume
- 8
- Issue
- 9
- Pages
- 733-750
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1992556352
- Cited by
- 703
- References
- 269
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.